| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/30/2003 | EP1330262A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 07/30/2003 | EP1330258A2 Kahalalide f formulation |
| 07/30/2003 | EP1330257A1 Gnrh analogues for treatment of urinary incontinence |
| 07/30/2003 | EP1330255A2 Use of a preparation of cimicifuga racemosa |
| 07/30/2003 | EP1330250A1 Rapidly disintegrating sustained release cefuroxime axetil composition |
| 07/30/2003 | EP1330249A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 07/30/2003 | EP1330246A1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 07/30/2003 | EP1330244A1 Compositions comprising modafinil compounds |
| 07/30/2003 | EP1330241A2 Use of tolterodine to treat asthma |
| 07/30/2003 | EP1330239A2 Delayed and sustained release formulations and method of use thereof |
| 07/30/2003 | EP1330238A1 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| 07/30/2003 | EP1330237A2 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 07/30/2003 | EP1330236A2 Formulation containing amoxicillin |
| 07/30/2003 | EP1330221A2 Medical compositions, dressings and methods for treating microbial infections of skin lesions |
| 07/30/2003 | EP1255534B1 Method for the preparation of microspheres which contain colloidal systems |
| 07/30/2003 | EP1233960B1 Polymorphic salt of an anti-migraine drug |
| 07/30/2003 | EP1233763B1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 07/30/2003 | EP1178832B1 Novel medicament compositions, based on tiotropium bromide and salmeterol |
| 07/30/2003 | EP1178787B1 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof |
| 07/30/2003 | EP1171100B1 Solubilized pharmaceutical composition for parenteral administration |
| 07/30/2003 | EP1161234B1 Treatment of pulmonary hypertension by inhalation of benzindene prostaglandins |
| 07/30/2003 | EP1075256B1 Arylhydrocarbon receptor ligand antagonists |
| 07/30/2003 | EP1056442B1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 07/30/2003 | EP0983058B1 Medicinal aerosol products |
| 07/30/2003 | EP0942780B1 Coated particles, methods of making and using |
| 07/30/2003 | EP0941067B1 Stable glassy state powder formulations |
| 07/30/2003 | EP0906124B1 Device and method for encapsulated gene therapy |
| 07/30/2003 | EP0904062B1 Sustained release ionic conjugate |
| 07/30/2003 | EP0783482B1 Cationic transport reagents |
| 07/30/2003 | EP0779818B1 Liquid immunoglobulin formulations |
| 07/30/2003 | EP0748190B1 PROGESTOGEN-FREE FORMULATIONS OF GnRH AND ESTROGEN FOR TREATING BENIGN GYNECOLOGICAL DISORDERS |
| 07/30/2003 | EP0697814B1 Pour-on formulations containinng polymeric material, glycols and glycerides |
| 07/30/2003 | CN2562917Y Laser punching device for plaster material |
| 07/30/2003 | CN2562769Y Shanjia paste for curing hyperplasia of mammary glands and mastadenitis |
| 07/30/2003 | CN2562768Y Anti-infection wound adhesive plaster |
| 07/30/2003 | CN2562767Y Multifunctional adhesive sheet with negative ion and biological electricity |
| 07/30/2003 | CN2562766Y Electric polemedicinal plaster for curing lumba vertebrae and cervical vertebrae diseases |
| 07/30/2003 | CN1433478A Novel colloid synthetic vectors for gene therapy |
| 07/30/2003 | CN1433477A Method of achieving persistent transgene expression |
| 07/30/2003 | CN1433423A Mono and disaccharide derivatives |
| 07/30/2003 | CN1433403A Solid pharmaceutical preparation |
| 07/30/2003 | CN1433319A Enzyme treatment for infection |
| 07/30/2003 | CN1433316A Biologically active agents and drugs |
| 07/30/2003 | CN1433314A Antimicrobial compositions and methods of use |
| 07/30/2003 | CN1433311A Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 07/30/2003 | CN1433309A Dual-release compositions of cyclooxygenase-2-inhibitor |
| 07/30/2003 | CN1433308A Cyclooxygenase-2 inhibitor compositions having rapid on set therapeutic effect |
| 07/30/2003 | CN1433303A Use of fumaric acid derivatives for treating mitochondrial diseases |
| 07/30/2003 | CN1433301A Novel formulation for counteracting ethylene response in plants, preparation process thereof and method using the same |
| 07/30/2003 | CN1433300A Treatment agent |
| 07/30/2003 | CN1432397A Rhinitis plaster |
| 07/30/2003 | CN1432389A Xuerongguyugao ointment for healing fracture and its prepn |
| 07/30/2003 | CN1432384A Ointment for removing necrosis, promoting granulation and invigorating bone and its prepn |
| 07/30/2003 | CN1432377A Plaster for treating rheumatic diseases and psoatic strain and its prepn process |
| 07/30/2003 | CN1432373A Nano granules for preventing AIDS and infectious viral blood disease |
| 07/30/2003 | CN1432368A Woodfrog egg oil capsule and its production process |
| 07/30/2003 | CN1432363A Transdermal Ligustrazine plaster and its prepn |
| 07/30/2003 | CN1432356A Prepn of biological regulating release capsule |
| 07/30/2003 | CN1116104C Method capable of scale preserving bioactivity matter by drying |
| 07/30/2003 | CN1116074C Buccal lozenge for preventing dental caries and its production method |
| 07/30/2003 | CN1116068C Medicine for treating ichthyosis and preparing process thereof |
| 07/30/2003 | CN1116067C Soft intelligence growth promoting capsule and its preparation method |
| 07/30/2003 | CN1116062C Exterior-applied ointment for lossing weight and its preparing process |
| 07/30/2003 | CN1116058C Chinese-medicinal plaster for treating spontaneousor night sweating and its preparing process |
| 07/30/2003 | CN1116057C Vaginitis treating medicine |
| 07/30/2003 | CN1116053C Liver protecting and pus drawing out ointment and its preparation |
| 07/30/2003 | CN1116051C Pref. of black ointment for curing furuncle, pain, swelling and skin ulcer |
| 07/30/2003 | CN1116044C Antisticking particle and powder containing sodium hyaluronate and their preparation process |
| 07/30/2003 | CN1116043C Process for preparation of coated azithromycin micropill |
| 07/30/2003 | CN1116039C Molecular dispersion composition with enhanced bioavailability |
| 07/30/2003 | CN1116033C Effervescent tablets for curing vaginities and its preparing method |
| 07/30/2003 | CN1116031C Emulsified inhalational anaesthetic for intravenous injection and its preparation |
| 07/30/2003 | CN1116030C Compositions for inhalation |
| 07/30/2003 | CN1116029C Tablet allowing prolonged release of sodium salt of tianeptine after administration by oral |
| 07/30/2003 | CN1116028C Nano realgar and its preparation |
| 07/29/2003 | US6600012 Lipid-modified muc-1 derivatives |
| 07/29/2003 | US6600010 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same |
| 07/29/2003 | US6599961 Polymethylmethacrylate augmented with carbon nanotubes |
| 07/29/2003 | US6599944 Ophtalmic compound with extended dwell time on the eye |
| 07/29/2003 | US6599931 Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone |
| 07/29/2003 | US6599928 Administering agent that inhibits the contraction or migration of smooth muscle cells; sustained dosage; biological stents |
| 07/29/2003 | US6599923 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 07/29/2003 | US6599897 Quetiapine granules |
| 07/29/2003 | US6599884 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
| 07/29/2003 | US6599883 Nasal delivery of xylitol |
| 07/29/2003 | US6599724 Pharmaceutical composition for use in the treatment of blood disorders |
| 07/29/2003 | US6599720 Methods for making poly-β-1→4-N-acetylglucosamine |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599627 Microencapsulation of drugs by solvent exchange |
| 07/29/2003 | US6599537 Antiradical, cytophotoprotective, tyrosinase and melanogenesis inhibiting and antiprotease effects |
| 07/29/2003 | US6599535 Bioavailability of drug substance, are convenient to administer, and are stable |
| 07/29/2003 | US6599534 Intimate mixture of a sapid agent, such as a sweetener, and an enhancer, proportion of sapid agent relative to the enhancer is substantially constant and equal in all powder particles. |
| 07/29/2003 | US6599533 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof |
| 07/29/2003 | US6599532 Controlled release alprazolam in the core optionally in combination with an anti-psychotic agent, in a rapid release external coat; smaller, easier to swallow |
| 07/29/2003 | US6599531 Granulating non-steroidal anti-inflammatory agent, colloidal silicon dioxide, disintegrant, binder and starch to form granules; blending with extra-granular material comprised of colloidal silica, disintegrant, filler and starch; compression |
| 07/29/2003 | US6599530 Oral compacted composition comprising catechol derivatives |
| 07/29/2003 | US6599529 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs) |
| 07/29/2003 | US6599528 Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances |
| 07/29/2003 | US6599527 Preparation of pharmaceutical compositions |
| 07/29/2003 | US6599525 Absorbent material and discontinuous semisolid ointment like coating; easily and comfortably removed from skin |